| [1] | QUEK J, CHAN KE, WONG ZY, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2023, 8( 1): 20- 30. DOI: 10.1016/S2468-1253(22)00317-X. |
| [2] | WONG VWS, EKSTEDT M, WONG GLH, et al. Changing epidemiology, global trends and implications for outcomes of NAFLD[J]. J Hepatol, 2023, 79( 3): 842- 852. DOI: 10.1016/j.jhep.2023.04.036. |
| [3] | CHEN JH, ZHOU ZH. Research progress of abnormal lipid metabolism and mitochondrial dysfunction in the pathogenesis and disease process of NAFLD[J]. Chin Hepatol, 2023, 28( 11): 1372- 1375. DOI: 10.3969/j.issn.1008-1704.2023.11.027. 陈佳豪, 周振华. 肝细胞脂质代谢异常与线粒体功能障碍在NAFLD发病和疾病进程中的研究进展[J]. 肝脏, 2023, 28( 11): 1372- 1375. DOI: 10.3969/j.issn.1008-1704.2023.11.027. |
| [4] | REN QN, SUN QM, FU JF. Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease[J]. Autophagy, 2024, 20( 2): 221- 241. DOI: 10.1080/15548627.2023.2254191. |
| [5] | XIN YJ, CHEN YY, YANG HL, et al. Effect of Xuanfuhua Decoction on a mouse model of nonalcoholic steatohepatitis induced by high-fat, high-fructose, and high-cholesterol diet[J]. J Clin Hepatol, 2023, 39( 6): 1340- 1350. DOI: 10.3969/j.issn.1001-5256.2023.06.014. 辛一敬, 陈逸云, 杨海琳, 等. 旋覆花汤对高脂高果糖高胆固醇饮食诱导非酒精性脂肪性肝炎小鼠模型的影响[J]. 临床肝胆病杂志, 2023, 39( 6): 1340- 1350. DOI: 10.3969/j.issn.1001-5256.2023.06.014. |
| [6] | ZHANG QY, ZHOU ZH. Mechanism of non-alcoholic steatohepatitis improved by Qizhu prescription based on AMPK signaling pathway[J]. Chin J Exp Tradit Med Formulae, 2024, 30( 8): 49- 56. DOI: 10.13422/j.cnki.syfjx.20232237. 张秋怡, 周振华. 基于AMPK信号通路探讨芪术方改善非酒精性脂肪性肝炎的机制[J]. 中国实验方剂学杂志, 2024, 30( 8): 49- 56. DOI: 10.13422/j.cnki.syfjx.20232237. |
| [7] | FAKHOURY-SAYEGH N, TRAK-SMAYRA V, SAYEGH R, et al. Fructose threshold for inducing organ damage in a rat model of nonalcoholic fatty liver disease[J]. Nutr Res, 2019, 62: 101- 112. DOI: 10.1016/j.nutres.2018.11.003. |
| [8] | CHEN Z, TIAN RF, SHE ZG, et al. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease[J]. Free Radic Biol Med, 2020, 152: 116- 141. DOI: 10.1016/j.freeradbiomed.2020.02.025. |
| [9] | SCHUSTER S, CABRERA D, ARRESE M, et al. Triggering and resolution of inflammation in NASH[J]. Nat Rev Gastroenterol Hepatol, 2018, 15( 6): 349- 364. DOI: 10.1038/s41575-018-0009-6. |
| [10] | ZHANG DW, ZHAO HY, LI QS, et al. Effect of AstragalosideIV and ginsenoside Rg1 on autophagy of myocardial tissue injury induced by ischemia-reperfusion injury in hyperlipidemic mice[J]. Chin Arch Tradit Chin Med, 2020, 38( 3): 60- 64. DOI: 10.13193/j.issn.1673-7717.2020.03.016. 张东伟, 赵宏月, 李全生, 等. 黄芪甲苷及人参皂苷Rg1对高脂大鼠心肌缺血再灌注损伤后心肌线粒体自噬的影响[J]. 中华中医药学刊, 2020, 38( 3): 60- 64. DOI: 10.13193/j.issn.1673-7717.2020.03.016. |
| [11] | SU J, GAO CT, XIE L, et al. Astragaloside II ameliorated podocyte injury and mitochondrial dysfunction in streptozotocin-induced diabetic rats[J]. Front Pharmacol, 2021, 12: 638422. DOI: 10.3389/fphar.2021.638422. |
| [12] | LI SD, CHEN XJ, LIU JK, et al. Signaling pathways involved in the active components of Polygonum cuspidatum in treatment of nonalcoholic fatty liver disease and their interaction[J]. J Clin Hepatol, 2022, 38( 4): 902- 907. DOI: 10.3969/j.issn.1001-5256.2022.04.033. 李淑娣, 陈欣菊, 刘江凯, 等. 虎杖活性成分治疗非酒精性脂肪性肝病的相关信号通路及相互作用[J]. 临床肝胆病杂志, 2022, 38( 4): 902- 907. DOI: 10.3969/j.issn.1001-5256.2022.04.033. |
| [13] | WANG Y, YANG ZY, LI SQ, et al. Regulatory mechanism of Polygonidine on endoplasmic reticulum stress in non⁃alcoholic fatty hepatocytes[J]. Anatomy Research, 2023, 45( 1): 57- 62. DOI: 10.20021/j.cnki.1671-0770.2023.01.10. 王懿, 杨志勇, 李书芹, 等. 虎杖苷对非酒精性脂肪性肝细胞内质网应激的调控机制[J]. 解剖学研究, 2023, 45( 1): 57- 62. DOI: 10.20021/j.cnki.1671-0770.2023.01.10. |
| [14] | ZHANG PF, CHENG XY, SUN HM, et al. Atractyloside protect mice against liver steatosis by activation of autophagy via ANT-AMPK-mTORC1 signaling pathway[J]. Front Pharmacol, 2021, 12: 736655. DOI: 10.3389/fphar.2021.736655. |
| [15] | UENO T, KOMATSU M. Autophagy in the liver: Functions in health and disease[J]. Nat Rev Gastroenterol Hepatol, 2017, 14( 3): 170- 184. DOI: 10.1038/nrgastro.2016.185. |
| [16] | MA XW, MCKEEN T, ZHANG JH, et al. Role and mechanisms of mitophagy in liver diseases[J]. Cells, 2020, 9( 4): 837. DOI: 10.3390/cells9040837. |
| [17] | LU YY, LI ZJ, ZHANG SQ, et al. Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation[J]. Theranostics, 2023, 13( 2): 736- 766. DOI: 10.7150/thno.79876. |
| [18] | LI L, JIA QL, WANG XX, et al. Chaihu Shugan San promotes gastric motility in rats with functional dyspepsia by regulating Drp-1-mediated ICC mitophagy[J]. Pharm Biol, 2023, 61( 1): 249- 258. DOI: 10.1080/13880209.2023.2166966. |
| [19] | LIU T, YU JN, LIU Y, et al. Effects of serum-free starvation on proliferative capacity of muscle satellite cells and expression of autophagy-related proteins LC3 and Beclin1[J]. Chin J Tissue Eng Res, 2019, 23( 11): 1657- 1661. DOI: 10.3969/j.issn.2095-4344.1062. 刘通, 于佳妮, 刘悦, 等. 去血清饥饿条件下肌卫星细胞增殖及自噬蛋白LC3、Beclin1的表达[J]. 中国组织工程研究, 2019, 23( 11): 1657- 1661. DOI: 10.3969/j.issn.2095-4344.1062. |
| [20] | SUI XY, XU P, DUAN CZ, et al. Advances in molecular function of p62 protein and its role in diseases[J]. Chin J Biotechnol, 2023, 39( 4): 1374- 1389. DOI: 10.13345/j.cjb.220681. 隋馨莹, 徐平, 段昌柱, 等. p62蛋白的分子功能及其在疾病中的研究进展[J]. 生物工程学报, 2023, 39( 4): 1374- 1389. DOI: 10.13345/j.cjb.220681. |
| [21] | YAO RQ, REN C, XIA ZF, et al. Organelle-specific autophagy in inflammatory diseases: A potential therapeutic target underlying the quality control of multiple organelles[J]. Autophagy, 2021, 17( 2): 385- 401. DOI: 10.1080/15548627.2020.1725377. |
